Wednesday November 25, 2020 12:29

Heathcare Press Release : 13 Jul 2020

World's First FDA IDE Coronary Patient Treated With a DEB Heathcare—13 Jul 20

MedAlliance has announced enrollment of the first patient in its study of SELUTION SLR(TM) 014 DEB for the treatment of In-Stent Restenosis (ISR). This is the first DEB accepted by the FDA for its 'Breakthrough Program'. The SELUTION SLR (Sustained Limus

Translated Tool from NCCN Measures Mental Health "Temperature" of People with Heathcare—13 Jul 20

The NCCN Distress Thermometer enables discussion and treatment of distress as part of routine care for people with cancer. This free resource is now translated into 46 languages for global accessibility. The National Comprehensive Cancer Network(R)